Combination medicine for infected fluid around the lungs
Part of Infections, Lungs & breathing clinical trials.
This study tests a two-medicine treatment (given through a chest tube) to help clear fluid around the lungs caused by TB or other infections. It aims to see if this treatment is safe and works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have fluid around your lungs (a pleural effusion).
- The fluid is caused by tuberculosis (TB) or another infection (not cancer or fluid from heart/liver problems).
- You are receiving a combination medicine through a chest tube (tissue plasminogen activator and deoxyribonuclease) to break up the fluid.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a once-daily enzyme treatment given through a chest tube to clear infected fluid from around the lungs. It may help people with complicated pneumonia or empyema who still have fluid buildup after initial drainage.
This trial tests two combinations of medicines for people with infected fluid around the lung that isn't draining well through a chest tube. The goal is to see which combination works better to clear the infection and improve recovery.
This trial compares using a special camera to look inside your chest (medical thoracoscopy) with standard care to treat infections in the fluid around the lungs. It aims to see if this procedure helps clear the infection better, possibly reducing the need for more invasive surgery or a longer hospital stay.
This study tests a two-step treatment for infected fluid around the lungs called empyema. It uses two medicines (tPA and DNase) given through your chest tube to break up and clear the fluid, which may help your lung expand and avoid surgery.
This study tests whether a lower dose of alteplase (a clot-busting medicine) given into the chest can improve healing of infected pleural fluid when drainage is incomplete. It may help reduce dosing-related side effects while still helping clear the infection-related fluid.
This study tests a new blood test that looks for TB DNA to see if it can help diagnose tuberculosis in people who have fluid around one lung. If the test works, it might make diagnosing TB faster and less invasive.
Hear when a new Tuberculous Pleural Effusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.